Elevance HealthWBO:ELV +0.30%82 PEG Ratio is 2.62 as of Jul. 09, 2026, which is 67% above its 10-year median of 1.57. GuruFocus rates WBO:ELV with a GF Score™ of 82/100 and a GF Value™ of €449.88 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 7 Healthcare Plans companies, Elevance Health ranks worse than 71.43% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Elevance Health's PEG Ratio or its related term are showing as below:
WBO:ELV'
s PEG Ratio Range Over the Past 10 Years
Min: 1.01 Med: 1.57 Max: 3.77
Current: 2.55
During the past 13 years, Elevance Health's highest PEG Ratio was 3.77. The lowest was 1.01. And the median was 1.57.
WBO:ELV's PEG Ratio is ranked worse than 71.43% of 7
companies
in the Healthcare Plans industry
Industry Median: 2.2
vs WBO:ELV: 2.55
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Elevance Health (WBO:ELV) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Elevance Health PEG Ratio Related Terms
Elevance Health PEG Ratio Historical Data
* Premium members only.
The historical data trend for Elevance Health's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Elevance Health's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health PEG Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Elevance Health's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Elevance Health (WBO:ELV) has a PEG Ratio of 2.62 as of Jul. 09, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Elevance Health and its competitors. This is 67% above median its historical median of 1.57. Over the past decade, Elevance Health's PEG Ratio has ranged from 1.01 to 3.77. According to the industry distribution chart, Elevance Health ranks #5 out of 7 companies in the Healthcare Plans industry, placing it in the top 71.4%.
Is Elevance Health's PEG Ratio too high?
Elevance Health's current PEG Ratio of 2.62 is 67% above median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 3.77. The Healthcare Plans industry median PEG Ratio is 2.20. Elevance Health's value of 2.62 is 19.1% above this industry median. Based on the distribution chart, Elevance Health ranks #5 out of 7 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Elevance Health has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's PEG Ratio compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #5 out of 7 companies for PEG Ratio. This places Elevance Health in the lower half of its industry. The industry median PEG Ratio is 2.20. Elevance Health's value of 2.62 is 19.1% above this benchmark. Historically, Elevance Health's own PEG Ratio has ranged from 1.01 to 3.77 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 2.20, Elevance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Plans company?
The median PEG Ratio among Healthcare Plans companies is 2.20, based on 7 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current PEG Ratio of 2.62 is 19.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median PEG Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current PEG Ratio is 2.62, which is 67% above median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €449.88, compared to a current price of €368.50 — trading 18.1% below its estimated fair value. The current PEG Ratio is 2.62, which is 67% above median its 10-year median of 1.57 and 19.1% above the Healthcare Plans industry median of 2.20. Elevance Health's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current PEG Ratio is 2.62 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (WBO:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of €368.50 is trading 18.1% below its estimated GF Value™ of €449.88.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for WBO:ELV:
PEG Ratio: 2.62 (67% above median its 10-year median of 1.57)
GF Value™: €449.88 vs. price of €368.50 (18.1% below fair value)
Industry Position: 19.1% above the Healthcare Plans median (#5 of 7)
No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
82GF Score
Get the complete analysis for WBO:ELV
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ELV has been successfully added to your 
